Monoclonal Antibodies To Delay Coagulation Factor XIII Activation

Invention Novelty

Value Proposition

Technology Description

UCSF researchers have developed antibodies that will delay coagulation factor XIII (FXIII)
activation during coagulation. In vitro, the researchers have shown a delay in FXIII activation
and reduction in clot size.

Application

Looking for Partners

Stage of Development

Related Materials

Data Availability